Early recognition, prompt intervention, effective management
Editeur : KARGER
Collection : fast facts
Année : 07/2019Immunotherapeutic products, and immune checkpoints inhibitors in particular, are increasingly used in the management of malignancies, both as monotherapies and in combination. Adverse events tend to be mild to moderate, but they can be severe or even life-threatening. Prompt recognition and effective management are vital.
[lire la quatrième du livre Managing immune-related adverse events in oncology]